Home > Healthcare > Medical Devices > Vitrification Market

Vitrification Market Trends

Report ID: GMI10188
Published Date: Jul 2024
Report Format: PDF

Download Free Sample

Vitrification Market Trends

The growing awareness and acceptance of IVF as a solution for infertility has been a key driver in the expansion of the market. As more individual become informed about IVF as a viable option, the demand for effective fertility preservation techniques such as vitrification, has surged. Also, vitrification enhances the success rates of IVF by preserving oocytes and embryos with minimal cellular damage. Thus, the increasing acceptance and adoption of IVF have fuelled the need for advanced cryopreservation methods, thereby propelling the growth of the market.

For instance, the first of June marks the beginning of World Infertility Awareness Month, dedicated to raising global awareness about the widespread impact of infertility on individuals of all genders, backgrounds, and lifestyles. This campaign aimed to support extending to management of fertility issues, fostering an inclusive workplace environment. This campaign aimed to increase awareness and consequently drive demand for fertility treatments.

Thus, the rising awareness and the proven benefits of vitrification in improving IVF outcomes have been instrumental in driving the expansion of this market.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global vitrification market was valued at USD 7.9 billion in 2023 and will grow at 10.1% CAGR during 2024-2032, driven by increasing demand for advanced cryopreservation techniques in fertility treatments.

The vitrification devices market reached a revenue of USD 3.7 billion in 2023 and will expand rapidly by 2032, as their precision and automation capabilities ensure consistent and reliable outcomes, which are crucial in fields like ART and biobanking.

U.S. vitrification market size was USD 3.4 billion in 2023 and will expand through 2032, owing to high infertility rate in the country along with the widespread adoption of ART technology.

Biotech, Inc., CooperSurgical Fertility Company, FERTIPRO NV, FUJIFILM Irvine Scientific, Genea BIOMEDX, IMV Technologies Group (Cryo Bio System), Kitazato Corporation, MFC Global, MINITÜB GMBH, NidaCon International AB, Optimas, Shenzhen VitaVitro Biotech, and Vitrolife among others.